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I just wanted to be a doctor
We need to be more than “just” doctors
Editor—Hunt articulates the feelings of
many doctors on discovering that the
effective practice of modern medicine
requires a range of skills beyond the
provision of direct clinical care.1 Her slightly
delayed entry into medicine may explain
why this issue is troubling her now, rather
than later in her career: certainly these are
sentiments I hear more commonly from
consultant colleagues than juniors.
However, to imagine that good medical
practice is confined to the delivery of care to
one patient at a time is to overlook the role
of doctors in organising healthcare systems
and delivery in the wider context. It is disap-
pointing that Hunt’s appraiser chose to
frame the process in terms of her trust’s par-
ticipation in the clinical negligence scheme,
since most junior doctors value well
conducted appraisals. Nevertheless, cheaper
insurance premiums for hospitals mean
more money to spend on health care, and
also indicate that organisations that carry
out effective appraisal make fewer clinical
errors: presumably these are both outcomes
that Hunt would approve of. Furthermore,
research and audit without the active
participation of doctors will soon become
clinically irrelevant or ineffective. We have a
wider responsibility for patient care that is
served by informed participation in these
and many other activities, such as teaching
and continuous quality improvement (which
also seem to get irritatingly in the way of a
narrowly focused approach to patient care).
However, all is not lost.Hunt appears well
placed to fall into the “Modernising Medical
Careers” vacuum that currently threatens to
swallow those junior doctors who are too old
for a foundation programme yet too young to
have secured a specialist registrar post. If this
does indeed curtail all opportunities for
career progression she may end up as “just” a
doctor after all.
Jonathan R Benger consultant in emergency medicine
United Bristol Healthcare Trust
Jonathan.Benger@ubht.nhs.uk
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Medicine and its representation
Editor—Hunt captures a key dynamic in
modern medicine.1 At all levels we seem to
have two jobs: firstly, to do the job and see
patients, and secondly, to prove that we have
done this activity, and to an appropriate
standard.
Doing the job is actually the core reason
for doctors to exist. It is the hardest part of
medicine. Meeting and dealing well with
people with all their pathology and their
personal particularities is hard work. By
comparison with this, going to meetings is
far easier.
To do our core job, doctors have to jump
through multiple hoops of audit, quality
assurance, clinical governance, appraisal,
and now revalidation. There is no evidence
that these time consuming activities do any-
thing for patient care. There is no evidence
that they measure what matters, or reliably
discriminate good practice from poor
practice. Indeed I propose that in their
current form they could all be stopped and
that no patient would be worse off.
However, for Hunt, and the rest of us, we
currently need to throw some salt on the
altar of audit and worship the idols of clini-
cal governance and research. It is now possi-
ble to make a career doing this, and so rarely
see any real patients at all. But never mind
the numbers, feel the depth of the evidence
based quality.
Meanwhile the discharge summaries do
not get written on time, and the readmission
rate is going up.
Peter G Davies general practitioner principal
Keighley Road Surgery, Illingworth, Halifax HX2 9LL
npgdavies@blueyonder.co.uk
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Managing conjunctivitis in
general practice
Recommendations depend on health
system
Editor—The conclusions drawn by Everitt
et al that delayed prescribing of antibiotics is
probably the most appropriate strategy for
managing acute conjunctivitis in primary
care are really dependent on the health sys-
tem.1 For the outcome of interest to
patients—duration of symptoms—immediate
antibiotics were clearly superior to delayed
or no antibiotics. Whether the outcome of
interest to the general practitioner—
reattendance of the patient—is superior or
inferior depends on the system. In the UK
system, reattendance is discouraged by gen-
eral practitioners; in Australia, with a
fee-for-service system, it is not.
Mark R Nelson chair, discipline of general practice
School of Medicine, University of Tasmania, Private
Bag 33, Hobart 7001, Australia
Mark.Nelson@utas.edu.au
Competing interests: None declared.
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Research into management strategies for
acute infective conjunctivitis
Editor—Neither Everitt et al nor Rietveld et
al seem to have consulted an ophthalmolo-
gist when designing their studies.1 2 There is
little evidence base to back up the clinical
features of a condition that many practi-
tioners take for granted. Ophthalmologists,
in particular, are aware that adenoviral con-
junctivitis tends to follow a distinct clinical
pattern: patients often complain of watering
and “grittiness” (initially in one eye before
involvement of the other), and on closer
questioning it often becomes apparent that
other family members or work colleagues
have had a similar problem. Pre-auricular
lymphadenopathy is also a helpful sign.
Symptoms may take up to three weeks to
resolve, and the patient has not uncom-
monly been using topical antibiotics for a
protracted period at the time of referral—
these contain preservatives that may trigger
an allergic response in an already inflamed
eye, thereby exacerbating the patient’s
symptoms. A diagnosis of chlamydial con-
junctivitis or allergic conjunctivitis is more
likely to be made in intractable cases than
one of bacterial conjunctivitis. In addition,
given the plethora of bacterial commensals
in the eye, the temptation to treat a swab
result rather than the patient should be
resisted.
Incorporating these key features of the
patient history and examination into their
analyses might have strengthened the results
of both studies. Rietveld et al established that
if a patient has had sticky eyes on waking
then he or she is more likely to have a posi-
tive bacterial culture. This does not necessar-
ily translate into a diagnosis of bacterial
conjunctivitis. The diagnosis of acute infec-
tive conjunctivitis in the study by Everitt et al
is too broad. Identifying the exact nature of
the pathogen associated with specific symp-
toms or signs would be valuable in this con-
text, and not particularly difficult to do.3–5
Often it is possible to identify the cause of
conjunctivitis by virtue of a good history and
basic examination alone. A move away from
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widespread empirical use of antibiotics for
acute conjunctivitis is to be welcomed, not
least because minimising patients’ attend-
ance at general practices and eye clinics
should help reduce the spread of outbreaks.
Scott J Robbie specialist registrar ophthalmology
Addenbrooke’s Hospital, Cambridge CB2 2QQ
srobbie1@hotmail.com
Kashif Qureshi glaucoma research fellow
Moorfields Eye Hospital, London EC1V 2PD
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Fixing the NHS
We need fewer and better managers
Editor—Black’s article embodies the prob-
lem in the NHS at the moment—a polarised
position with government, Department of
Health, NHS Executive, and managers often
on one side, and healthcare professionals on
the other.1 To the author, anyone who
criticises the current direction of the NHS is
“anti-reform.”
Many points in the article show the
problem that management consultants have
in oversimplifying the processes of the
NHS—for example, I visit my inpatients
every day, including weekends when not on
call. But how am I to discharge them into a
system where social service provision and
even transport home or pharmacies are not
available at the weekend? To help me
discharge patients appropriately, the whole
system of community care has to adjust as
well.
The statement that doctors do not have
the management expertise to know how to
organise process well is not true. Doctors
have been the driving force behind most
positive developments in the healthcare envi-
ronment. Hospital doctors have at least two
degree level qualifications, and often three.
Many also have qualifications inmanagement
or business or organisational psychology.
Every day they manage an extensive multi-
disciplinary team, with complex and ever
changing processes, deal face to face with
clients—the public—in some of the most
stressful situations possible. We are required
to maintain competency, keep up to date with
organisational as well as clinical change, and
we usually achieve that effectively.
This drive, necessary educational per-
formance, as well as at least 10 or 20 years’
training, clinical skill, and understanding of
how the NHS works is precisely what many
politicians and managers find personally
threatening and difficult to manage—and
end up criticising as “conservatism” or “anti-
reformist.” Doctors who voice these prob-
lems are immediately criticised as arrogant
or elitist—elitism being the greatest crime in
the homogenised mediocrity that often
seems to be the aspiration of New Labour
“reform.”
Paul L Thorpe spinal surgeon
Musgrove Park Hospital, Taunton TA1 3PX
plpjt@doctors.org.uk
Competing interests: None declared.
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NHS is undermanaged, but
overadministered
Editor—The NHS is indeed under-
managed, and even many of those managers
have no formal management qualification.1
So why do so many clinicians believe there
are too many managers? Because, as the
author points out, there is too much
bureaucracy, which is performed by admin-
istrators who are called managers. If this dis-
tinction between management and adminis-
tration were made explicit, and the centre
demanded less bureaucracy, managers
might be both recognised and rewarded for
their skills. I have the excellent good fortune
to work with a superb manager, and if
all trusts had sufficient good managers,
there would be no need for management
consultants.
Stephen R Kirkham consultant in palliative medicine
Poole Hospital NHS Trust, Poole BH15 2JB
stephen.kirkham@poole.nhs.uk
Competing interests: SRK is associate medical
director at Poole Hospital NHS Trust.
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Summary of rapid responses
Stephen Black’s article resulted in more
than 30 lively responses from general
practitioners and hospital doctors, almost
exclusively from the United Kingdom. Most
were in agreement that what is needed is not
more, but better, managers, with pertinent
training suggested as a solution. Most
agreed, however, that management
consultants—such as the author himself—are
expensive and of limited usefulness since
they are not involved in the organisation.
The opinions of doctors and nurses should
have been sought out, said many. A couple
lamented the polarisation that had occurred
between clinicians and managers, which was
not helping in a climate of financial and
staffing constraints.
Opinions differed about whether NHS
managers needed a medical qualification,
but possessing an understanding of the
working processes within the NHS was seen
as absolutely essential. Indeed, one of the
criticisms repeatedly levelled at the author
was that he had displayed no such
understanding: his recommendations on
afternoon and weekend discharges in
particular were perceived by correspondents
to demonstrate this lack of insight. The NHS
was seen as possessing an unmeasurable
quality that management consultants, with
their “obsession with the measurable” fail to
grasp—targets for waiting times being a case
in point, where nothing had actually
improved.
Similarly hotly debated was the issue of
staffing levels: the absolute necessity of more
“frontline” staff was expressed by numerous
correspondents (especially by doctors work-
ing in emergency medicine), not more man-
agers or administrators at their expense.
Investment in IT systems was seen as a posi-
tive future undertaking, but most pointed
out the primary need to remedy the current
situation and invest in staff. Several doctors
reported having had some form of manage-
ment training and had found this extremely
beneficial in expanding their professional
skills. Most were united in stating that while
doctors do not necessarily make good man-
agers, managers certainly could not do doc-
tors’ jobs, and specific training, close
cooperation with colleagues, and good com-
munication might help a new breed of
“medical managers” emerge, as well as
establish a common framework of manage-
ment skills around healthcare delivery. Doc-
tors are expressing a willingness to tackle
management tasks and roles, with appropri-
ate training—and what they do not want is
more bureaucrats, administrators, or manag-
ers without competence. I wonder what the
managers think.
Birte Twisselmann assistant editor (web)
(btwisselmann@bmj.com)
Heatwaves and hospital staff
Highest level was not reached
Editor—The editorial by Kovats raises
some important issues about public health
action in response to severe weather.1 The
article states that in July the United
Kingdom experienced a more severe heat-
wave than in 2003. Although the “average”
temperature for July broke all records for
any month, the temperatures in 2003 were
higher for longer. This distinction is
recognised in the heatwave plan for
England, where alerts are based on duration
as well as on daytime and night-time
temperature.
It is obviously very early to be drawing
firm conclusions about the impact of the
plan, just over two weeks after the last “level
3” in England, but we are currently carrying
out a rapid evaluation. There are some signs
that it may well have had the intended
effects. Preliminary reports from inspectors
and regulation managers in the Commis-
sion for Social Care Inspection, for example,
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indicate a high level of awareness among
care home managers and staff about what to
do—with many homes taking special steps to
keep residents hydrated, cool with fans, and
out of the sun. The increase in calls related
to heatstroke and sunstroke to NHS Direct
was slightly less than the peak levels experi-
enced during August 2003, and at the peak
of temperatures still accounted for less than
1% of all calls. Reports of heatstroke during
the hottest week amounted to only 30 cases
from 460 practices.2
As Kovats states, vulnerable people
need to be actively identified and cared for
in a heatwave and this is what we have built
into the plan. Kovats says there is much
confusion about identifying people at risk
as well as the specific advice to be given, but
it is not clear on what basis she says this.
Our early impressions are that some of the
very specific advice in the plan has been
well understood and acted on—to the
benefit of some of the most vulnerable
people.
She is right that we do not have real time
mortality data. Improvements in the systems
for handling death registration data nation-
ally may help from next year. What data we
do have for July are impossible to interpret,
but at a national level variation appears to be
within normal limits. Further analysis
including regional age-specific analysis will
be completed as soon as data become avail-
able over the next few weeks.
Kovats is also right to highlight that
climate change needs to be taken into
account in health protection—this is a public
health challenge we must acknowledge.
This year, the heatwave plan was
launched with much encouragement to
those responsible for its implementation to
“mainstream” it, and get it perceived in the
same sort of light as the pandemic flu plan.
Those individuals and organisations with
responsibility for enhancing our overall
resilience need to “own” the plan. Fortu-
nately the July heatwave did not reach the
highest level, level 4. In future years, it may
well do so. As Kovats implies, it is not just the
health service and social care that need to be
prepared.
Mike W Gill regional director of public health
Brian McCloskey
Department of Health, London SW1 2NS
mike.gill@dh.gsi.gov.uk
Competing interests: MWG was the main
architect of the heatwave plan for England.
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Taking the temperatures may be
important
Editor—We read with interest Kovats’s
review of the impact of the recent heat wave
on public health.1 We noticed several
patients on the general surgical ward during
this period with fevers up to 38°C but
normal inflammatory markers. This led us
to investigate the temperatures of the staff in
the hospital.
We assessed the tympanic temperature,
using the Kendall Genius first temp
tympanic thermometer, of 21 members of
staff at 830 pm on 19 July 2006, the end of
the hottest day in north Wales. A few weeks
later on a cold day, temperatures were taken
at the same time of day from 10 further staff
members. Out of the 21 temperatures
recorded on the hot day, only four were
normal (below 37°C). The mean tempera-
ture was 37.33°C and the maximum
temperature was 37.9°C. Among the tem-
peratures recorded on the cooler day, the
mean temperature was 36.36°C and the
maximum temperature was 37°C. The
difference between the two samples was sta-
tistically significant using an unpaired t test
(P < 0.001).
Although our sample sizes are small
there is statistically significant evidence to
show unexpectedly high temperatures in
healthy staff members during the recent
heat wave. This may be due to the sudden
increase in temperature after a long cold
winter in north Wales.
These results are important to remem-
ber when managing patients with high tem-
peratures but normal inflammatory markers
during a heat wave to avoid inappropriate
use of antibiotics.
J Cleo Oliver specialist registrar general surgery
Venkat S S Neelapala senior house officer general
surgery
Gwynedd Hospital, Bangor LL57 2PW
cleo.oliver@yahoo.co.uk
Competing interests: None declared.
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Preventing postoperative
nausea and vomiting
Prevention in context
Editor—Metoclopramide is one of the
drugs that we reviewed in our recent
Cochrane meta-analysis.1 We also found that
metoclopramide was effective. We found
that, compared with placebo, the average
relative risk for postoperative nausea and
vomiting was 0.76 for all doses of metoclo-
pramide, which compares to 0.89, 0.75, and
0.63 for 10 mg, 25 mg, and 50 mg of meto-
clopramide in the study reported by Wallen-
born et al.2 We would like to comment on
the useful information that Wallenborn’s
study provides in this context.
Wallenborn et al provided the most
information linking antiemetic dose with
effect. We found a clear pattern of
increasing effect in our review for droperi-
dol, but less convincing patterns for other
antiemetics, including metoclopramide.1
Wallenborn et al did not measure a
significant difference between 10 mg of
metoclopramide and placebo. From our
systematic review, we think that 10 mg of
intravenous metoclopramide does have an
effect, but not sufficient to be detected at the
P = 0.05 level in 788 participants with a
control risk of 0.23.
We included 737 studies involving
103 237 people.1 We found convincing
evidence that nine drugs were effective. But
the results for all nine were skewed, probably
by publication bias. The results for metoclo-
pramide were skewed the least, as illustrated
by a funnel plot that was only mildly
asymmetric. As Sweeney comments in his
editorial,3 many clinicians either dismiss
metoclopramide or consider it to be a weak
antiemetic. This conservative expectation
has probably resulted in the least distortion
of effect for metoclopramide, perhaps by
“allowing” the publication of studies that
show little or no antiemetic effect.
We found that the funnel plots for newer
agents, either in comparison with placebo or
older antiemetics, were markedly skewed.
We think that clinicians should be cautious,
in both extolling the virtues of new
antiemetics and in discarding older drugs,
particularly when rare adverse reactions are
detected only after a large number are
exposed to a new drug.
In the United Kingdom 10 mg of
intravenous metoclopramide costs about
£0.27. The metoclopramide cost of prophy-
laxis for 1000 people would be £270 (€396;
$510), £675, and £1350 at the three doses in
this study. This compares to about £5990 for
4 mg of ondansetron and £8600 for 1 mg of
granisetron.
Finally we disagree with Sweeney’s
suggestion that a head to head trial of meto-
clopramide and dexamethasone versus a
5-HT3 antagonist combined with dexam-
ethasone would be the next logical step.3
This proposed study would add little to all
the other studies of metoclopramide and
5-HT3 antagonists. If clinicians remain set
on more “primary” research, despite the
incomplete synthesis of the research already
published, they should concentrate on the
detection of rare serious side effects.
John B Carlisle consultant anaesthetist
Torbay Hospital, Torquay, Devon TQ2 7AA
john.carlisle@nhs.net
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